vs

Side-by-side financial comparison of BALCHEM CORP (BCPC) and National Vision Holdings, Inc. (EYE). Click either name above to swap in a different company.

National Vision Holdings, Inc. is the larger business by last-quarter revenue ($487.3M vs $270.7M, roughly 1.8× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 0.7%, a 14.2% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (8.1% vs 7.9%). BALCHEM CORP produced more free cash flow last quarter ($33.8M vs $30.3M). Over the past eight quarters, National Vision Holdings, Inc.'s revenue compounded faster (7.6% CAGR vs 7.5%).

Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.

Vision Research is an international company that manufactures high-speed digital cameras based in Wayne, New Jersey. Their cameras are marketed under the Phantom brand, and are used in a broad variety of industries including: defense, industrial product development, manufacturing, automotive, scientific research, and entertainment. Vision Research is a business unit of the Materials Analysis Division of Ametek Inc., a global manufacturer of electronic instruments and electromechanical devices.

BCPC vs EYE — Head-to-Head

Bigger by revenue
EYE
EYE
1.8× larger
EYE
$487.3M
$270.7M
BCPC
Growing faster (revenue YoY)
BCPC
BCPC
+0.1% gap
BCPC
8.1%
7.9%
EYE
Higher net margin
BCPC
BCPC
14.2% more per $
BCPC
14.9%
0.7%
EYE
More free cash flow
BCPC
BCPC
$3.6M more FCF
BCPC
$33.8M
$30.3M
EYE
Faster 2-yr revenue CAGR
EYE
EYE
Annualised
EYE
7.6%
7.5%
BCPC

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
BCPC
BCPC
EYE
EYE
Revenue
$270.7M
$487.3M
Net Profit
$40.3M
$3.4M
Gross Margin
Operating Margin
20.5%
2.0%
Net Margin
14.9%
0.7%
Revenue YoY
8.1%
7.9%
Net Profit YoY
8.7%
139.8%
EPS (diluted)
$1.25
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCPC
BCPC
EYE
EYE
Q1 26
$270.7M
Q4 25
$263.6M
Q3 25
$267.6M
$487.3M
Q2 25
$255.5M
$486.4M
Q1 25
$250.5M
$510.3M
Q4 24
$240.0M
$437.3M
Q3 24
$239.9M
$451.5M
Q2 24
$234.1M
$451.7M
Net Profit
BCPC
BCPC
EYE
EYE
Q1 26
$40.3M
Q4 25
$39.2M
Q3 25
$40.3M
$3.4M
Q2 25
$38.3M
$8.7M
Q1 25
$37.1M
$14.2M
Q4 24
$33.6M
$-28.6M
Q3 24
$33.8M
$-8.5M
Q2 24
$32.1M
$-3.1M
Gross Margin
BCPC
BCPC
EYE
EYE
Q1 26
Q4 25
35.6%
Q3 25
35.7%
Q2 25
36.4%
Q1 25
35.2%
Q4 24
36.0%
Q3 24
35.6%
Q2 24
35.5%
Operating Margin
BCPC
BCPC
EYE
EYE
Q1 26
20.5%
Q4 25
19.8%
Q3 25
20.4%
2.0%
Q2 25
20.1%
3.4%
Q1 25
20.4%
5.1%
Q4 24
19.8%
-5.8%
Q3 24
20.0%
-2.0%
Q2 24
19.6%
0.1%
Net Margin
BCPC
BCPC
EYE
EYE
Q1 26
14.9%
Q4 25
14.9%
Q3 25
15.1%
0.7%
Q2 25
15.0%
1.8%
Q1 25
14.8%
2.8%
Q4 24
14.0%
-6.5%
Q3 24
14.1%
-1.9%
Q2 24
13.7%
-0.7%
EPS (diluted)
BCPC
BCPC
EYE
EYE
Q1 26
$1.25
Q4 25
$1.21
Q3 25
$1.24
$0.04
Q2 25
$1.17
$0.11
Q1 25
$1.13
$0.18
Q4 24
$1.03
$-0.36
Q3 24
$1.03
$-0.11
Q2 24
$0.98
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCPC
BCPC
EYE
EYE
Cash + ST InvestmentsLiquidity on hand
$72.9M
$56.0M
Total DebtLower is stronger
$236.5M
Stockholders' EquityBook value
$1.3B
$858.8M
Total Assets
$1.7B
$2.0B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCPC
BCPC
EYE
EYE
Q1 26
$72.9M
Q4 25
$74.6M
Q3 25
$65.1M
$56.0M
Q2 25
$65.4M
$48.5M
Q1 25
$49.9M
$80.0M
Q4 24
$49.5M
$73.9M
Q3 24
$73.7M
$81.2M
Q2 24
$63.7M
$179.5M
Total Debt
BCPC
BCPC
EYE
EYE
Q1 26
Q4 25
Q3 25
$236.5M
Q2 25
$255.6M
Q1 25
$244.7M
Q4 24
$248.6M
Q3 24
$252.8M
Q2 24
$143.9M
Stockholders' Equity
BCPC
BCPC
EYE
EYE
Q1 26
$1.3B
Q4 25
$1.3B
Q3 25
$1.3B
$858.8M
Q2 25
$1.3B
$850.6M
Q1 25
$1.2B
$836.2M
Q4 24
$1.1B
$816.3M
Q3 24
$1.2B
$840.0M
Q2 24
$1.1B
$843.4M
Total Assets
BCPC
BCPC
EYE
EYE
Q1 26
$1.7B
Q4 25
$1.7B
Q3 25
$1.7B
$2.0B
Q2 25
$1.7B
$2.0B
Q1 25
$1.6B
$2.0B
Q4 24
$1.6B
$2.0B
Q3 24
$1.6B
$2.0B
Q2 24
$1.6B
$2.1B
Debt / Equity
BCPC
BCPC
EYE
EYE
Q1 26
Q4 25
Q3 25
0.28×
Q2 25
0.30×
Q1 25
0.29×
Q4 24
0.30×
Q3 24
0.30×
Q2 24
0.17×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCPC
BCPC
EYE
EYE
Operating Cash FlowLast quarter
$40.1M
$46.6M
Free Cash FlowOCF − Capex
$33.8M
$30.3M
FCF MarginFCF / Revenue
12.5%
6.2%
Capex IntensityCapex / Revenue
2.3%
3.4%
Cash ConversionOCF / Net Profit
0.99×
13.83×
TTM Free Cash FlowTrailing 4 quarters
$83.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCPC
BCPC
EYE
EYE
Q1 26
$40.1M
Q4 25
$67.3M
Q3 25
$65.6M
$46.6M
Q2 25
$47.3M
$54.3M
Q1 25
$36.5M
$32.2M
Q4 24
$52.3M
$30.3M
Q3 24
$51.3M
$27.9M
Q2 24
$45.0M
$51.5M
Free Cash Flow
BCPC
BCPC
EYE
EYE
Q1 26
$33.8M
Q4 25
Q3 25
$30.3M
Q2 25
$42.4M
Q1 25
$12.0M
Q4 24
$-1.7M
Q3 24
$4.1M
Q2 24
$31.9M
FCF Margin
BCPC
BCPC
EYE
EYE
Q1 26
12.5%
Q4 25
Q3 25
6.2%
Q2 25
8.7%
Q1 25
2.4%
Q4 24
-0.4%
Q3 24
0.9%
Q2 24
7.1%
Capex Intensity
BCPC
BCPC
EYE
EYE
Q1 26
2.3%
Q4 25
Q3 25
3.4%
Q2 25
2.4%
Q1 25
4.0%
Q4 24
7.3%
Q3 24
5.3%
Q2 24
4.3%
Cash Conversion
BCPC
BCPC
EYE
EYE
Q1 26
0.99×
Q4 25
1.72×
Q3 25
1.63×
13.83×
Q2 25
1.23×
6.22×
Q1 25
0.98×
2.27×
Q4 24
1.56×
Q3 24
1.52×
Q2 24
1.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons